RXRX - Recursion Pharmaceuticals, Inc.
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $-0.28
|
Rev Est: $24.6M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$11.00
DETAILS
HIGH:
$11.00
LOW:
$11.00
MEDIAN:
$11.00
CONSENSUS:
$11.00
UPSIDE:
211.61%
Market Cap:
1.41B
Volume:
15,614,825
Avg Volume:
21,777,221
52 Week Range:
2.98-9.74
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.95
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
800
IPO Date:
2021-04-16
EPS (TTM):
-1.69
P/E Ratio:
-4.00
Revenue (TTM):
58.84M
Total Assets:
1.45B
Total Debt:
108.49M
Cash & Equiv:
594.35M
Rev Growth (5Y):
102.8%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-36.7%
Debt/Equity:
0.10
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $-0.36 | $-0.38 | +5.3% | $5.2M | $24.6M | -78.9% |
| 2025-08-05 | $-0.41 | $-0.35 | -17.1% | $19.1M | $19.9M | -4.1% |
| 2025-05-05 | $-0.50 | $-0.44 | -13.6% | $14.7M | $14.0M | +5.6% |
| 2025-02-28 | $-0.53 | $-0.44 | -20.5% | $4.5M | $19.0M | -76.3% |
| 2024-11-06 | $-0.34 | $-0.33 | -3.0% | $26.1M | $18.2M | +43.5% |
| 2024-08-08 | $-0.40 | $-0.35 | -14.3% | $14.4M | $13.3M | +8.7% |
| 2024-05-09 | $-0.39 | $-0.43 | +9.3% | $13.8M | $12.7M | +9.0% |
| 2024-02-27 | $-0.40 | $-0.46 | +13.0% | $10.9M | $20.4M | -46.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 58.84M | 43.88M | 39.68M | 10.00M | 3.41M | 1.71M |
| Net Income | (463.66M) | (328.07M) | (239.48M) | (186.48M) | (87.01M) | (62.52M) |
| EPS | -1.69 | -1.58 | -1.36 | -1.05 | -0.52 | -0.37 |
| Total Assets | 1.45B | 653.70M | 701.29M | 610.35M | 298.58M | 101.43M |
| Total Debt | 108.49M | 50.67M | 51.01M | 11.48M | 15.66M | 16.17M |
| Cash & Equivalents | 594.35M | 391.56M | 549.91M | 285.12M | 262.13M | 69.88M |
| Operating Cash Flow | (359.17M) | (287.78M) | (83.52M) | (158.61M) | (45.40M) | (57.04M) |
| Free Cash Flow | (372.87M) | (300.33M) | (120.88M) | (198.41M) | (52.13M) | (60.95M) |
| FCF per Share | -1.36 | -1.44 | -0.69 | -1.17 | -0.31 | -0.37 |
| Book Value | 1.03B | 463.44M | 485.81M | 542.94M | (206.29M) | (124.27M) |
| Cash & ST Investments | 594.35M | 391.56M | 549.91M | 516.56M | 262.13M | 69.88M |
| ROC Equity | -0.45 | -0.71 | -0.49 | -0.34 | N/A | N/A |